A detailed history of Ameriprise Financial Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 156,447 shares of MEDP stock, worth $51.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
156,447
Previous 124,466 25.69%
Holding current value
$51.9 Million
Previous $50.3 Million 28.09%
% of portfolio
0.02%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$372.0 - $424.34 $11.9 Million - $13.6 Million
31,981 Added 25.69%
156,447 $64.4 Million
Q1 2024

May 15, 2024

SELL
$284.87 - $413.31 $28.3 Million - $41.1 Million
-99,437 Reduced 44.41%
124,466 $50.3 Million
Q4 2023

Feb 14, 2024

BUY
$227.52 - $312.68 $4.79 Million - $6.58 Million
21,055 Added 10.38%
223,903 $68.6 Million
Q3 2023

Nov 14, 2023

SELL
$233.98 - $281.67 $2.62 Million - $3.15 Million
-11,196 Reduced 5.23%
202,848 $49.1 Million
Q2 2023

Aug 14, 2023

BUY
$187.26 - $240.17 $8.11 Million - $10.4 Million
43,327 Added 25.38%
214,044 $51.4 Million
Q1 2023

May 15, 2023

BUY
$174.31 - $239.52 $512,297 - $703,949
2,939 Added 1.75%
170,717 $32.1 Million
Q4 2022

Feb 14, 2023

SELL
$153.06 - $226.57 $4.48 Million - $6.63 Million
-29,270 Reduced 14.85%
167,778 $35.6 Million
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $1.71 Million - $2.15 Million
-11,758 Reduced 5.63%
197,048 $30.9 Million
Q2 2022

Aug 15, 2022

SELL
$130.2 - $168.03 $1.54 Million - $1.99 Million
-11,833 Reduced 5.36%
208,806 $31.3 Million
Q1 2022

May 16, 2022

SELL
$138.87 - $214.31 $15.6 Million - $24 Million
-111,987 Reduced 33.67%
220,639 $36.1 Million
Q4 2021

Feb 14, 2022

BUY
$182.74 - $227.9 $3.88 Million - $4.84 Million
21,249 Added 6.82%
332,626 $72.3 Million
Q3 2021

Nov 15, 2021

BUY
$170.18 - $198.21 $14,635 - $17,046
86 Added 0.03%
311,377 $58.9 Million
Q2 2021

Aug 16, 2021

BUY
$158.62 - $194.3 $2.43 Million - $2.98 Million
15,331 Added 5.18%
311,291 $55 Million
Q1 2021

May 17, 2021

BUY
$132.02 - $168.26 $460,881 - $587,395
3,491 Added 1.19%
295,960 $48.5 Million
Q4 2020

Feb 12, 2021

BUY
$109.38 - $149.19 $1.69 Million - $2.3 Million
15,439 Added 5.57%
292,469 $40.7 Million
Q3 2020

Nov 16, 2020

SELL
$92.95 - $130.61 $11.5 Million - $16.2 Million
-124,051 Reduced 30.93%
277,030 $30.9 Million
Q2 2020

Aug 14, 2020

SELL
$68.08 - $95.68 $4.09 Million - $5.75 Million
-60,112 Reduced 13.03%
401,081 $37.3 Million
Q1 2020

May 15, 2020

SELL
$61.71 - $101.95 $1.22 Million - $2.01 Million
-19,763 Reduced 4.11%
461,193 $33.8 Million
Q4 2019

Feb 14, 2020

BUY
$70.08 - $84.64 $15.6 Million - $18.8 Million
222,251 Added 85.91%
480,956 $40.4 Million
Q3 2019

Nov 14, 2019

SELL
$62.38 - $85.89 $3.88 Million - $5.34 Million
-62,211 Reduced 19.39%
258,705 $21.7 Million
Q2 2019

Aug 14, 2019

SELL
$53.64 - $65.42 $14 Million - $17.1 Million
-261,294 Reduced 44.88%
320,916 $21 Million
Q1 2019

May 15, 2019

SELL
$49.38 - $70.58 $6.43 Million - $9.19 Million
-130,218 Reduced 18.28%
582,210 $34.3 Million
Q4 2018

Feb 14, 2019

SELL
$46.97 - $63.98 $391,729 - $533,593
-8,340 Reduced 1.16%
712,428 $37.7 Million
Q3 2018

Nov 14, 2018

BUY
$43.25 - $63.74 $1.92 Million - $2.82 Million
44,281 Added 6.55%
720,768 $44.1 Million
Q2 2018

Aug 14, 2018

BUY
$34.03 - $45.46 $1.72 Million - $2.3 Million
50,525 Added 8.07%
676,487 $29.1 Million
Q1 2018

May 15, 2018

BUY
$32.03 - $39.05 $9.07 Million - $11.1 Million
283,099 Added 82.57%
625,962 $21.8 Million
Q4 2017

Feb 12, 2018

SELL
$32.46 - $38.31 $2.38 Million - $2.81 Million
-73,238 Reduced 17.6%
342,863 $12.4 Million
Q3 2017

Nov 07, 2017

BUY
$27.43 - $33.11 $11.4 Million - $13.8 Million
416,101
416,101 $13.3 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.3B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.